Search Results - "Marsden, Katherine A"

Evaluating a CLL susceptibility variant in ITGB2 in families with multiple subtypes of hematological malignancies by Blackburn, Nicholas B., Marthick, James R., Banks, Annette, Charlesworth, Jac C., Marsden, Katherine A., Lowenthal, Ray M., Blangero, John, Dickinson, Joanne L.

Get full text

Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring by Bereznicki, Luke R, Jackson, Shane L, Peterson, Gregory M, Jeffrey, Ella C, Marsden, Katherine A, Jupe, David M

“…Aim: To evaluate the accuracy of the CoaguChek XS international normalised ratio (INR) monitor compared with the laboratory method. Methods: The accuracy and…”
Get full text

A retrospective examination of mean relative telomere length in the Tasmanian Familial Hematological Malignancies Study by BLACKBURN, NICHOLAS B, CHARLESWORTH, JAC C, MARTHICK, JAMES R, TEGG, ELIZABETH M, MARSDEN, KATHERINE A, SRIKANTH, VELANDAI, BLANGERO, JOHN, LOWENTHAL, RAY M, FOOTE, SIMON J, DICKINSON, JOANNE L

“…Telomere length has a biological link to cancer, with excessive telomere shortening leading to genetic instability and resultant malignant transformation…”
Get full text

Anticipation in familial hematologic malignancies by Tegg, Elizabeth M., Thomson, Russell J., Stankovich, Jim M., Banks, Annette, Marsden, Katherine A., Lowenthal, Ray M., Foote, Simon J., Dickinson, Joanne L.

“…We describe a collection of 11 families with ≥ 2 generations of family members whose condition has been diagnosed as a hematologic malignancy. In 9 of these…”
Get full text

Evidence for a common genetic aetiology in high‐risk families with multiple haematological malignancy subtypes by Tegg, Elizabeth M., Thomson, Russell J., Stankovich, Jim, Banks, Annette, Flowers, Ceri, McWhirter, Rebekah, Panton, Jean, Piaszczyk, Anne, Bahlo, Melanie, Marsden, Katherine A., Lowenthal, Ray M., Foote, Simon J., Dickinson, Joanne L.

“…Summary A family history of a haematological malignancy (HM) is known to be a risk factor for HMs. However, collections of large families with multiple cases…”
Get full text

Improving Clinical Outcomes for Hospital Patients Initiated on Warfarin by Bereznicki, Luke R, Jackson, Shane L, Morgan, Steven M, Boland, Camille, Marsden, Katherine A, Jupe, David M, Vial, Janet H, Peterson, Gregory M

“…ABSTRACT Background Studies have demonstrated that the risk of warfarin‐related complications is highest in the first 90 days of treatment, while quality…”
Get full text

Cryopreserved human haematopoietic stem cells retain engraftment potential after extended (5–14 years) cryostorage by Spurr, Elisabeth E, Wiggins, Nicole E, Marsden, Katherine A, Lowenthal, Raymond M, Ragg, Scott J

“…Harvesting of stem cells during the early phases of treatment with no immediate intention to perform a stem cell transplant is becoming an increasingly common…”
Get full text

Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice by Jackson, Shane L., Bereznicki, Luke R., Peterson, Gregory M., Marsden, Katherine A., Jupe, David M. L., Vial, Janet H., Rasiah, Rohan L., Misan, Gary, Williams, Sharon M.

“…Objective:  To compare the accuracy and clinical usefulness of the near‐patient testing CoaguChek S INR monitor in rural medical practice. Design, setting and…”
Get full text

Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes by Sullivan, S A, Marsden, K A, Lowenthal, R M, Jupe, D M, Jones, M E

“…As part of an epidemiological survey of myelodysplastic syndromes (MDS) in southern Tasmania, 62 MDS patients identified over a 2 year period were tested for…”
Get more information

Dose-dependent effects of prostaglandin D2 on hemodynamics, renal function, and blood gas analyses by Rao, P S, Cavanagh, D, Dietz, J R, Marsden, K A, O'Brien, W F, Spaziani, E

“…Dose-response effects of prostaglandin D2 (0.125, 0.25, 0.5, and 0.75 micrograms/kg/min) infused intravenously in pentobarbital-anesthetized dogs were studied…”
Get more information

Comparison of immunofluorescence and immunoperoxidase techniques for demonstration of phenotype and monoclonality in lymphoproliferative disorders by Marsden, K A, Lowenthal, R M

“…To determine whether a simple immunoperoxidase (IP) technique could replace the traditional immunofluorescence (IF) technique (by fluorescence microscopy) for…”
Get more information

Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses by Rao, P S, Cavanagh, D, Marsden, K A, Knuppel, R A, Spaziani, E

“…This canine study was designed to evaluate the effects of the intravenous infusion of coliform endotoxin with a simultaneous infusion of prostaglandin D2…”
Get more information

Acute leukemia with t(1;3)(p36;q21), evolution to t(1;3)(p36;q21), t(14;17)(q32;q21), and loss of red cell A and Le(b) antigens by Marsden, K A, Pearse, A M, Collins, G G, Ford, D S, Heard, S, Kimber, R I

“…At transformation of refractory anemia with ring sideroblasts to acute nonlymphocytic leukemia (ANLL) the bone marrow cells of a 75-year-old woman showed three…”
Get more information

The effect of prostaglandin D2 (PGD2) on circulating eosinophils by Marsden, K A, Rao, P S, Cavanagh, D, Spaziani, E

“…Infusion of prostaglandin D2 (PGD2) into dogs for 60 minutes at a rate of 1 microgram/kg/min produced a marked and rapid reduction in circulating eosinophils…”
Get more information